Modular Medical (NASDAQ:MODD – Get Free Report) is one of 212 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Modular Medical to similar businesses based on the strength of its risk, analyst recommendations, institutional ownership, profitability, earnings, valuation and dividends.
Profitability
This table compares Modular Medical and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Modular Medical | N/A | -159.51% | -137.42% |
Modular Medical Competitors | -616.54% | -293.32% | -27.39% |
Earnings & Valuation
This table compares Modular Medical and its peers revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Modular Medical | N/A | -$13.88 million | -0.98 |
Modular Medical Competitors | $1.23 billion | $62.31 million | 14.91 |
Risk & Volatility
Modular Medical has a beta of 0.11, suggesting that its share price is 89% less volatile than the S&P 500. Comparatively, Modular Medical’s peers have a beta of 1.28, suggesting that their average share price is 28% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current recommendations for Modular Medical and its peers, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Modular Medical | 0 | 0 | 1 | 0 | 3.00 |
Modular Medical Competitors | 1163 | 3677 | 7480 | 194 | 2.54 |
Modular Medical currently has a consensus price target of $4.25, indicating a potential upside of 266.38%. As a group, “Surgical & medical instruments” companies have a potential upside of 35.29%. Given Modular Medical’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Modular Medical is more favorable than its peers.
Insider and Institutional Ownership
29.4% of Modular Medical shares are held by institutional investors. Comparatively, 46.0% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 59.2% of Modular Medical shares are held by company insiders. Comparatively, 14.4% of shares of all “Surgical & medical instruments” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Modular Medical peers beat Modular Medical on 7 of the 13 factors compared.
About Modular Medical
Modular Medical, Inc. operates as a development stage medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for diabetes. The company was founded in 1998 and is headquartered in San Diego, California.
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.